Docci D, Bilancioni R, Baldrati L, Capponcini C, Turci F, Feletti C
Servizio di Nefrologia e Dialisi, Ospedale M. Bufalini, Cesena, Italy.
Clin Nephrol. 1990 Aug;34(2):88-91.
The incidence of elevated acute phase reactants, measured by nephelometry, was examined in 69 otherwise uncomplicated hemodialysis patients in comparison with 30 healthy subjects. Increased C-reactive protein was found in 40.6% of the patients (p less than 0.001 vs controls) and the degree of increase was correlated with the duration of hemodialysis. Haptoglobin was increased in 33.3% (p less than 0.01 vs controls). High levels of alpha-1-acid glycoprotein and alpha-1-proteinase inhibitor were present in 15.9% and 2.9%, respectively; these frequencies were not significantly different from controls. No differences between pre- and postdialysis values were observed. It is concluded that, unlike C-reactive protein, both alpha-1-acid glycoprotein and alpha-1-proteinase inhibitor maintain an excellent specificity in hemodialysis patients. Vice versa, haptoglobin may be unreliable as an acute phase reactant in these patients because of the unacceptably high false-positive rate.
通过比浊法测定,对69例无其他并发症的血液透析患者与30名健康受试者进行比较,检测急性期反应物升高的发生率。40.6%的患者C反应蛋白升高(与对照组相比,p<0.001),且升高程度与血液透析时间相关。33.3%的患者触珠蛋白升高(与对照组相比,p<0.01)。分别有15.9%和2.9%的患者α1-酸性糖蛋白和α1-蛋白酶抑制剂水平升高;这些频率与对照组无显著差异。透析前和透析后的值未观察到差异。结论是,与C反应蛋白不同,α1-酸性糖蛋白和α1-蛋白酶抑制剂在血液透析患者中均保持良好的特异性。反之,由于假阳性率过高,触珠蛋白作为这些患者的急性期反应物可能不可靠。